From: Hierarchical Bayesian modelling of disease progression to inform clinical trial design in centronuclear myopathy
CNM mutationa
MTM1
DNM2
Gender
 Males
41
6
 Females
3
9
Age (years)
 0–2
12
0
 2–6
10
1
 6–16
13
 > 16